Grants and Contributions:
Title:
IP Assist - Level 3
Agreement Number:
1013863
Agreement Value:
$27,780.00
Agreement Date:
Dec 4, 2023 - May 31, 2024
Description:
The project will support development of intellectual property capacity within the firm.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Toronto, Ontario, CA M5G 1L7
Reference Number:
172-2023-2024-Q4-1013863
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
714319308
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 61 days. The total amended value is 27,780 dollars.
Amendment Date
Mar 26, 2024
Recipient's Operating Name:
Noa Therapeutics
Recipient's Legal Name:
Noa Therapeutics Inc.
Federal Riding Name:
University--Rosedale
Federal Riding Number:
35110
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
54171
Amendments: